Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00739401 · ClinicalTrials.gov registry record · NA

Suprarenal Proximal Cuff Study for Treatment of Abdominal Aortic Aneurysm

A NA study of Abdominal Aortic Aneurysm, sponsored by Endologix.

Completed
Registry status
NA
Development phase
44
Enrollment target
8
Study locations

NCT00739401 is a NA study of Abdominal Aortic Aneurysm that has completed, run by Endologix. The registered enrollment target is 44 participants, below the 451-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (90% lower). The trial reports 8 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00739401, a NA study of Abdominal Aortic Aneurysm, has completed, sponsored by Endologix.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target
8
Study locations

Study Summary

The use of a suprarenal extension device during the index AAA procedure to accommodate the patient's anatomy and to prevent or repair leakage.

Conditions Studied

Interventions

  • DEVICE Suprarenal Proximal Cuff Extension

Study Locations (8)

Florida

  • Mount Sinai Medical Center - Miami Beach
  • Munroe Regional Medical Center - Ocala
  • Orlando Regional Hospital - Orlando
  • Sacred Heart Hospital - Pensacola Research Consultants - Pensacola

North Carolina

  • Duke University Hospital - Durham
  • East Carolina University - Brody School of Medicine - Greenville

Illinois

  • Methodist Medical Center of Illinois - Peoria

Indiana

  • Deaconess Hospital - The Heart Group - Evansville

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2006-05-05
Est. Completion 2009-08
Phase NA

Sponsor

Endologix

17 total trials

What the Registry Record Tells You About NCT00739401

The ClinicalTrials.gov registry entry for NCT00739401 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 451-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (90% lower). The listed sponsor is Endologix, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Suprarenal Proximal Cuff Extension is the first listed.

NCT00739401 reports 8 study locations spanning 4 distinct geographic areas - top geographies include Florida, North Carolina, Illinois.

Frequently Asked Questions

What is clinical trial NCT00739401 about?

NCT00739401 is a clinical study titled "Suprarenal Proximal Cuff Study for Treatment of Abdominal Aortic Aneurysm". The use of a suprarenal extension device during the index AAA procedure to accommodate the patient's anatomy and to prevent or repair leakage.

What is the current status of trial NCT00739401?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2006-05-05. Estimated completion is 2009-08.

What conditions does trial NCT00739401 study?

This clinical trial studies the following conditions: Abdominal Aortic Aneurysm.

What interventions are being tested in trial NCT00739401?

The interventions under investigation include: Suprarenal Proximal Cuff Extension (DEVICE).

Who is sponsoring clinical trial NCT00739401?

This trial is sponsored by Endologix, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00739401 being conducted?

This trial has 8 study locations across Florida, Illinois, Indiana, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Abdominal Aortic Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.